National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI

Clinical Trials Reporting Program

    Posted: 04/24/2009
Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
About CTRP

NCI's new Clinical Trials Reporting Program (CTRP) fulfills a recommendation made by the NCI Clinical Trials Working Group (CTWG) to the National Cancer Advisory Board.

The purpose of the program is to establish a comprehensive database containing regularly updated information on on all NCI-funded clinical trials. Grantees will enter specific information about each clinical trial into the database. NCI will internally transfer to CTRP information on CTEP, CCR and DCP trials, eliminating the need for awardees to enter information on these trials. NCI will use this information to coordinate research efforts to optimize our nation's investment in cancer research.

NCI initiated a phased launch of CTRP, which started January 2009 with a focus on registering interventional trials only. The registration of observational, ancillary and correlative studies will begin in 2010.

Check back regularly for updates.


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov